Accounting for microdosing classic psychedelics

B. BEATON ; H. COPES ; M. WEBB ; A. HOCHSTETLER ; P. S. HENDRICKS | 2020
Dans Journal of Drug Issues (Vol.50, n°1, January 2020) Article : Périodique

Microdosing classic psychedelics (e.g., LSD [lysergic acid diethylamide] and psilocybin) is the practice of taking small amounts of these substances to bring about various positive life changes. Little is known about the subjective experiences a[...]

Plus d'info

Ajouter à la sélection

Examining the nexus between prescription opioid and heroin abuse

K. R. KERLEY ; M. WEBB ; O. H. GRIFFIN | 2019
Dans Deviant Behavior (Vol.40, n°9, 2019) Article : Périodique

Opioid use has long been a problem in the United States and heroin has shown to be particularly dangerous. Whereas the profile of heroin users changed throughout the 1900s, prior to the 1990s, most users were city-dwellers living on the fringes [...]

Plus d'info

Ajouter à la sélection

Narrative identity, rationality, and microdosing classic psychedelics

M. WEBB ; H. COPES ; P. S. HENDRICKS | 2019
Dans International Journal of Drug Policy (Vol.70, August 2019) Article : Périodique

Background: Microdosing involves ingesting a small dose of a classic psychedelic (e.g., LSD and psilocybin) at regular intervals for prolonged periods. The practice is said to reduce anxiety, improve mood, and offer several creative and practica[...]

Plus d'info

Ajouter à la sélection